Login
$HNGE
$121.75 +$0.46 (0.38%) After hours

$HNGE 8-K SEC Filings

Filed On Filing
02 Nov 2026 8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more

San Francisco, California – November 2, 2026 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2026 and provided a business update.

21 Aug 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

On August 18, 2026, Hinge Health, Inc. (the “Company”) entered into an office lease agreement (the “Lease”) with 50 Beale Street LLC, a Delaware limited liability company (the “Landlord”), for approximately 119,278 rentable square feet l...

04 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more

San Francisco, California – August 4, 2026 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the second quarter ended June 30, 2026 and provided a business update.

09 Jun 2026 8-K: Regulation FD Disclosure

San Francisco, CA – June 9, 2026 – Tomorrow, June 10, Hinge Health, Inc. (NYSE: HNGE) will host its inaugural Investor Day at Movement - the company’s annual conference that brings employers, health plans, consultants, providers and clin...

04 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

On June 3, 2026, Hinge Health, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). The Company’s stockholders voted on two proposals at the Annual Meeting, each of which is described below as well as...

05 May 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

San Francisco, California – May 5, 2026 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the first quarter ended March 31, 2026.

17 Mar 2026 8-K: Departure/Election of Directors or Officers; Compensation

On March 16, 2026, the Board of Directors (the “Board”) of Hinge Health, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Tyler Sloat to serve as a member of the Board, effecti...

10 Feb 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

San Francisco, California – February 10, 2026 – Hinge Health, Inc. (NYSE: HNGE) today announced record financial results for the quarter and year ended December 31, 2025.

12 Nov 2025 8-K: Regulation FD Disclosure; Other Events

San Francisco, California – November 12, 2025 – Hinge Health, Inc. (NYSE: HNGE) today announced that its board of directors has authorized a $250 million share repurchase program.

04 Nov 2025 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

San Francisco, California – November 4, 2025 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2025.

13 Aug 2025 8-K: Other Events

In connection with the initial public offering (the “IPO”) of Class A common stock of Hinge Health, Inc. (the “Company”), all of the Company’s directors and executive officers, the selling stockholders in the IPO, and certain other recor...

05 Aug 2025 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

San Francisco, California – August 5, 2025 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the second quarter ended June 30, 2025.

23 May 2025 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Other Events

The address of the registered office of Hinge Health, Inc. (the “Corporation”) in the State of Delaware, and the name of its registered agent at such address, shall be as set forth in the Corporation’s certificate of incorporation, as th...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support